tirzepatide injection new market Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds and slowing down the emptying of food from the stomach FDA approves new obesity drug
Description
Vision changes

LL-37 is a cathelicidin, which is a host defense peptide found in all animals, ranging from frogs to fish to humans

The manufacturer conducts rigorous stability testing to establish expiration dates and storage requirements that ensure the medication retains its therapeutic effectiveness throughout its shelf life when stored as directed

It has also been shown to induce LL-37 production by intestinal epithelial cells, adding one good reason to eat your veggies

The most effective GLP-1 drug for weight loss currently (as of early 2026) is tirzepatide, marketed under the names Zepbound (for weight loss) and Mounjaro (for diabetes)

Lyophilized research vials: reconstitution determines everything Lyophilized vials add another variable: the reconstitution volume
